Life Sciences
Tempus and Recursion Extend Data Partnership Through 2029 and Add TxFM RNA Model License
Tempus and Recursion have extended their data partnership through November 2029, set $42 million of committed payments over three years and added a worldwide license to Recursion’s TxFM RNA model.
Read full report →